+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2017-09-19Number of Pages: 180

Stem Cells Market (Product - Adult Stem Cell, Human Embryonic Stem Cell, and Induced Pluripotent Stem Cell; Sources – Autologous and Allogeneic; Application - Regenerative Medicine and Drug Discovery and Development; End Users - Therapeutic Companies, Cell and Tissues Banks, Tools and Reagent Companies, and Service Companies) - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2017 - 2025

Global Stem Cells Market: Snapshot

In order to come up with stem cell based therapies, most companies operating in the global stem cells market are trying to raise funds from overseas organizations. They are also working out collaborations and partnerships with pharmaceutical organizations in order to bolster their positions.

Besides such efforts to expand their portfolios and presence, which are proving beneficial to the global stem cells market, the rising instances of chronic conditions and increasing investments by pharmaceutical and biopharmaceutical companies for stem cell research are also having a positive impact on the market. The rising number of stem cell donors, superior quality stem cell banking facilities, and increasing research and development are other factors that are serving to underpin the growth in the global stem cells market.

Buoyed by the above factors, the global market for stem cells is expected to register a robust CAGR of 13.8% during the period from 2017 to 2025, predicts a report by Transparency Market Research. At this rate, the market will likely attain a value of US$270.5 bn by 2025, as per the report.

global stem cell market revenue

Ability to Overcome Ethical Challenges Makes Induced Pluripotent Stem Cells Most Promising Segment 

Depending upon the type of products, the global stem cell market can be divided into adult stem cells, human embryonic stem cells, induced pluripotent stem cells, etc. The segment of adult stem cells, among them, holds a leading share in the market. This is because of their ability to multiply into trillions of specialized cells which may lower the risks of rejection and repair tissue damage. As per UCB, a global biopharmaceutical company, Canada is home to over 100,000 people with Parkinson’s disease and about another 6,600 new cases are diagnosed annually in the nation.

The human embryonic stem cell segment trails the segment of adult stem cells vis-à-vis market share in revenue. The induced pluripotent stem cells segment again is an emerging segment that holds out a lot of potential. Induced pluripotent stem cells, which can be created from the tissue of the patient needing the transplantation, helps avoid the problem of immune rejection. Besides, it also tackles ethical challenges as the cells are harvested from a willing adult without harming them. These are the key driving factors for the market growth of the segment.

Investments in Stem Cells Research Propels North America Market to Fore

Geography-wise, the key segments of the global stem cells market are North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. At present, North America dominates the market because of the substantial investments in the field, impressive economic growth, rising instances of target chronic diseases, and technological progress. The market in North America will likely retain its dominant share in the near future to become worth US$167.33 bn by 2025.

Europe comes in the second position after North America in the global stem cells market. Germany, in Europe, is said to be powering the region’s growth as patients from other countries in Europe as well as the U.S. and Canada travel to Germany to receive medical treatments at reasonable costs. By 2025, the region is slated to rake in a revenue of US$67.47 bn. Vis-à-vis growth, on the other hand, Asia Pacific stem cells market is expected to run the show by clocking a 14.6% CAGR from 2017 to 2025.

STEMCELL Technologies Inc., Astellas Pharma Inc., Cellular Engineering Technologies Inc., BioTime Inc., Takara Bio Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics Inc., Cytori Therapeutics, Inc., Osiris Therapeutics, Inc., and Caladrius Biosciences, Inc. are to name a few of the prominent players in the region.

Global Stem Cells Market: Overview

Stem cells are widely used in treating cancer and many other immune system diseases. Currently stem cells are been investigated for the treatment in wound healing, Alzheimer’s diseases, spinal cord injury, osteoarthritis and others. The property of stem cell of developing into different cells has been widely useful in treating different diseases. Stem cells also a property that they have a property to develop into a tissue or organ specific cell, only for heart and pancreas the stem cells divide only under special conditions. 

The global stem cells market is segmented according to product type, sources, application, end users and geography. By product type the market is segmented into adult stem cells, human embryonic stem cells, induced pluripotent cells and others. According to sources the market is segmented into autologous and allogeneic. In terms of application the market is segmented into regenerative medicine and drug discovery & development.  By end users the global stem cells market is segmented into therapeutic companies, cell & tissue banks, tools & reagent companies and service companies. In terms of geography the global stem cells market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Global Stem Cells Market: Research Methodology

The research is a combination of primary and secondary research, conducted for understanding and arriving at trends, used to forecast the expected revenue of the stem cells market in the near future. Primary research formed the bulk of our research efforts with information collected from in-depth interviews and discussions with a number of key industry experts and opinion leaders. Secondary research involved study of company websites, annual reports, press releases, investor presentations, analyst presentation and various international and national databases.

The report provides estimated market size in terms of US$ Mn for each by product type, source, application, end user, and geography for the period 2015 to 2025, considering the macro and micro environmental factors. The number of procedures and their market demand as per their use, prevalence rate of disease, annual revenue generated by products of each sub segment, trends in industry, end user trend, and adoption rate across all the geographies.

The market report comprises an elaborated executive summary, which includes market snapshot that provides information about various segments of the market. It also provides information and data analysis of the market with respect to market segments based on product type, source, application, end-user, and geography. The market overview section of the report analyzes market dynamics such as drivers, restraints and opportunities that influences the global stem cells market in the current and future scenario.

Global Stem Cells Market: Competitive Analysis

Market share analysis among the market players is analyzed to signify the contribution of these players in the market in terms of percentage share. All these factors will help the market players to decide about the business strategies and plans to strengthen their positions in the global market. Based on geography, the market has been analyzed for major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The study also covers detailed country analysis contributing majorly in the stem cells market.

The report also profiles the major players in the market and provides various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major companies profiled in the global stem cells market are STEMCELL Technologies Inc., Astellas Pharma Inc., Cellular Engineering Technologies Inc., BioTime Inc., Takara Bio Inc., U.S. Stem Cell, Inc., BrainStorm Cell Therapeutics Inc., Cytori Therapeutics, Inc., Osiris Therapeutics, Inc., Caladrius Biosciences, Inc. and others.

The global stem cells market has been segmented as follows:

Global Stem Cells Market, by Product Type

  • Adult Stem Cells
  • Human Embryonic Stem Cells
  • Induced Pluripotent Stem Cells
  • Others

Global Stem Cells Market, by Source

  • Autologous
  • Allogeneic

Global Stem Cells Market, by Application

  • Regenerative Medicine
  • Drug Discovery & Development

Global Stem Cells Market, by End Users  

  • Therapeutic Companies
  • Cell & Tissue Banks
  • Tools & Reagent Companies
  • Service Companies 

Global Stem Cells Market, by Geography

  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Europe
    • U.K.
    • Germany
    • Spain
    • Italy
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • Japan
    • China
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA


 
 
Back To Top